365 related articles for article (PubMed ID: 25246577)
1. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
2. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
3. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
4. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
[TBL] [Abstract][Full Text] [Related]
5. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.
Dougherty JD; Fomchenko EI; Akuffo AA; Schmidt E; Helmy KY; Bazzoli E; Brennan CW; Holland EC; Milosevic A
Cancer Res; 2012 Sep; 72(18):4856-68. PubMed ID: 22865458
[TBL] [Abstract][Full Text] [Related]
6. Mosaic analysis with double markers reveals tumor cell of origin in glioma.
Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H
Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.
Bartesaghi S; Graziano V; Galavotti S; Henriquez NV; Betts J; Saxena J; Minieri V; A D; Karlsson A; Martins LM; Capasso M; Nicotera P; Brandner S; De Laurenzi V; Salomoni P
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1059-64. PubMed ID: 25583481
[TBL] [Abstract][Full Text] [Related]
8. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
9. EZH2 Palmitoylation Mediated by ZDHHC5 in p53-Mutant Glioma Drives Malignant Development and Progression.
Chen X; Ma H; Wang Z; Zhang S; Yang H; Fang Z
Cancer Res; 2017 Sep; 77(18):4998-5010. PubMed ID: 28775165
[TBL] [Abstract][Full Text] [Related]
10. Glial progenitors as targets for transformation in glioma.
Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
[TBL] [Abstract][Full Text] [Related]
12. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Solga AC; Gianino SM; Gutmann DH
Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
[TBL] [Abstract][Full Text] [Related]
13. KDM1 is a novel therapeutic target for the treatment of gliomas.
Sareddy GR; Nair BC; Krishnan SK; Gonugunta VK; Zhang QG; Suzuki T; Miyata N; Brenner AJ; Brann DW; Vadlamudi RK
Oncotarget; 2013 Jan; 4(1):18-28. PubMed ID: 23248157
[TBL] [Abstract][Full Text] [Related]
14. Double minute amplification of mutant PDGF receptor α in a mouse glioma model.
Zou H; Feng R; Huang Y; Tripodi J; Najfeld V; Tsankova NM; Jahanshahi M; Olson LE; Soriano P; Friedel RH
Sci Rep; 2015 Feb; 5():8468. PubMed ID: 25683249
[TBL] [Abstract][Full Text] [Related]
15. MADM gives new insights into gliomagenesis.
Lei L; Canoll P
J Mol Cell Biol; 2011 Oct; 3(5):273-5. PubMed ID: 21926086
[TBL] [Abstract][Full Text] [Related]
16. Premalignant Oligodendrocyte Precursor Cells Stall in a Heterogeneous State of Replication Stress Prior to Gliomagenesis.
Sutcliffe MD; Galvao RP; Wang L; Kim J; Rosenfeld LK; Singh S; Zong H; Janes KA
Cancer Res; 2021 Apr; 81(7):1868-1882. PubMed ID: 33531372
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.
Banerjee S; Crouse NR; Emnett RJ; Gianino SM; Gutmann DH
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15996-6001. PubMed ID: 21896734
[TBL] [Abstract][Full Text] [Related]
18. Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Espinosa-Jeffrey A; Paez PM; Cheli VT; Spreuer V; Wanner I; de Vellis J
PLoS One; 2013; 8(12):e76963. PubMed ID: 24324574
[TBL] [Abstract][Full Text] [Related]
19. Expression of proteolipid protein gene in spinal cord stem cells and early oligodendrocyte progenitor cells is dispensable for normal cell migration and myelination.
Harlow DE; Saul KE; Culp CM; Vesely EM; Macklin WB
J Neurosci; 2014 Jan; 34(4):1333-43. PubMed ID: 24453324
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]